This makes him a trustworthy healthcare provider for administering Semaglutide GLP-1 and monitoring its impact on your health
Is NAD+ therapy safe for weight loss
DOI: Published online: July 1, 2025 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea Corresponding author: Hye Jin Yoo Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 148 Gurodong-ro, Guro-gu, Seoul 08308, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

Retatrutide is being studied in that same general category of peptide weight loss therapy , but with an important twist: it is designed as a triple-agonist. What that means is that retatrutide targets three receptors involved in weight regulation and metabolism: GLP-1 , which supports satiety and improves glucose control GIP , another incretin hormone involved in metabolic signaling Glucagon receptors , which are linked to energy balance and how the body uses fuel This three-pronged approach is a big reason its creating buzz
Bottom line Retatrutide is a triple-action peptide, emerging as a new weight loss medication with greater efficacy than existing medications
Adjusting your fiber intake alongside GLP-1 support requires a strategic approach